{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T03:33:26Z","timestamp":1768534406424,"version":"3.49.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bestpracticeobgyn.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.bpobgyn.2016.01.006","type":"journal-article","created":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T23:33:18Z","timestamp":1455060798000},"page":"140-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Metabolic syndrome, diet and exercise"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0127-6482","authenticated-orcid":false,"suffix":"Dr","given":"Sunita M.C.","family":"De Sousa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Prof","given":"Robert J.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2016.01.006_bib1","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the Southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib2","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A\u00a0survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib3","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib4","first-page":"2434","article-title":"A\u00a0prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"85","author":"Asunci\u00f3n","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib5","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tem.2014.12.003","article-title":"Metabolic risk in PCOS: phenotype and adiposity impact","volume":"26","author":"Moran","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/humrep\/des463","article-title":"Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp","volume":"28","author":"Stepto","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib8","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/humupd\/dms030","article-title":"Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"18","author":"Lim","year":"2012","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib9","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib10","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib11","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib12","series-title":"Evidence-based guideline for the assessment and management of polycystic ovary syndrome","author":"PCOS Australian Alliance","year":"2011"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib13","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","article-title":"Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment","volume":"83","author":"DeUgarte","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib14","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/humrep\/16.9.1995","article-title":"Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome","volume":"16","author":"Norman","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib15","first-page":"1004","article-title":"Sex hormone binding globulin, but not testosterone, is associated with the metabolic syndrome in overweight and obese women with polycystic ovary syndrome","volume":"36","author":"Moran","year":"2013","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib16","series-title":"Novel insights into the pathophysiology and treatment of PCOS","first-page":"122","article-title":"Polycystic ovary syndrome: prognosis and risk of comorbidity","author":"Hardy","year":"2013"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1472-6823-14-76","article-title":"Prevalence and predictors of metabolic abnormalities in Chinese women with PCOS: a cross-sectional study","volume":"14","author":"Li","year":"2014","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib18","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1093\/humrep\/deg440","article-title":"Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet","volume":"18","author":"Carmina","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib19","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1210\/jc.2004-2279","article-title":"Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters","volume":"90","author":"Carmina","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib20","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1471-0528.2006.00973.x","article-title":"The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome","volume":"113","author":"Lord","year":"2006","journal-title":"BJOG"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib21","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/jc.2005-2430","article-title":"Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome","volume":"91","author":"Lo","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib22","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ecl.2006.05.001","article-title":"Polycystic ovarian syndrome: the next cardiovascular dilemma in women?","volume":"35","author":"Srikanthan","year":"2006","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF03345564","article-title":"Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome","volume":"31","author":"Essah","year":"2008","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib25","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2265.2008.03247.x","article-title":"Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)","volume":"69","author":"Diamanti-Kandarakis","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib27","first-page":"517","article-title":"Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance 1","volume":"86","author":"Vgontzas","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib28","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/jc.2005-2774","article-title":"Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome","volume":"91","author":"Setji","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib29","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/humupd\/dmr025","article-title":"Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome","volume":"17","author":"Toulis","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib30","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.ATV.20.11.2414","article-title":"Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women","volume":"20","author":"Talbott","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib31","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1210\/jc.2003-030334","article-title":"Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome","volume":"88","author":"Christian","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib32","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1210\/jc.2003-032049","article-title":"The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study","volume":"89","author":"Orio","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib33","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1210\/jc.2007-0425","volume":"93","author":"Shaw","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib34","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/humupd\/dmr001","article-title":"PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis","volume":"17","author":"De Groot","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib35","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","article-title":"A\u00a0meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"12","author":"Boomsma","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib36","doi-asserted-by":"crossref","first-page":"558.e1","DOI":"10.1016\/j.ajog.2011.03.021","article-title":"Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis","volume":"204","author":"Kjerulff","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib37","doi-asserted-by":"crossref","first-page":"d6309","DOI":"10.1136\/bmj.d6309","article-title":"Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study","volume":"343","author":"Roos","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib38","series-title":"IVF in the medically complicated patient: a guide to management","first-page":"91","article-title":"The patient with polycystic ovary syndrome","author":"De Sousa","year":"2014"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib39","series-title":"Polycystic ovary syndrome","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zawadzki","year":"1992"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib41","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib42","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1093\/oxfordjournals.humrep.a136280","article-title":"Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome","volume":"10","author":"Norman","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib43","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1080\/09513590701536246","article-title":"Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population","volume":"23","author":"Pehlivanov","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib44","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1093\/humrep\/del306","article-title":"Is the PCOS diagnosis solved by ESHRE\/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma?","volume":"21","author":"Belosi","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib45","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2265.2007.02954.x","article-title":"Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS","volume":"67","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib46","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1093\/humrep\/det262","article-title":"Prevalence of polycystic ovary syndrome in women in China: a large community-based study","volume":"28","author":"Li","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib47","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.fertnstert.2008.03.007","article-title":"Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome","volume":"91","author":"Carmina","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib48","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S1472-6483(10)60902-9","article-title":"The ESHRE\/ASRM consensus on polycystic ovary syndrome (PCOS)\u2013an extended critical analysis","volume":"14","author":"Geisth\u00f6vel","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib49","series-title":"Evidence-based methodology workshop on polycystic ovary syndrome: final report","author":"National Institutes of Health","year":"2012"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib50","doi-asserted-by":"crossref","first-page":"62","DOI":"10.5694\/mja11.10553","article-title":"Prevalence of polycystic ovary syndrome in a sample of indigenous women in Darwin, Australia","volume":"196","author":"Boyle","year":"2012","journal-title":"Med J Aust"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib51","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1210\/jc.2004-0229","article-title":"Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome","volume":"90","author":"Ehrmann","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib52","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.steroids.2013.04.011","article-title":"Diagnosis of adolescent polycystic ovary syndrome","volume":"78","author":"Hardy","year":"2013","journal-title":"Steroids"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib53","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jpag.2009.04.004","article-title":"Characteristics of adolescents presenting to a multidisciplinary clinic for polycystic ovarian syndrome","volume":"23","author":"Bekx","year":"2010","journal-title":"J\u00a0Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1520-037X.2007.07255.x","article-title":"Guidelines for prevention of cardiovascular disease in women: a summary of recommendations","volume":"10","author":"Mosca","year":"2007","journal-title":"Prev Cardiol"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib55","series-title":"Clinical practice guidelines for the management of overweight and obesity in adults, adolescents and children in Australia","author":"National Health and Medical Research Council","year":"2013"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib56","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women 1","volume":"84","author":"Legro","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib57","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1210\/jc.2007-1549","article-title":"Position statement: glucose intolerance in polycystic ovary syndrome\u2014a position statement of the androgen excess society","volume":"92","author":"Salley","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib58","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.fertnstert.2011.08.035","article-title":"Hemoglobin A1c as a tool for the diagnosis of type 2 diabetes in 208 premenopausal women with polycystic ovary syndrome","volume":"96","author":"Velling Magnussen","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib59","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A\u00a0new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib60","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1210\/jc.2010-1187","article-title":"Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome","volume":"96","author":"Tasali","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007506.pub3","article-title":"Lifestyle changes in women with polycystic ovary syndrome","author":"Moran","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib62","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1210\/jc.2015-2778","article-title":"Randomized controlled trial of preconception interventions in infertile women with polycystic ovary syndrome","volume":"100","author":"Legro","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib63","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/oxfordjournals.humrep.a135772","article-title":"Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women","volume":"10","author":"Clark","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib64","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.fertnstert.2005.12.041","article-title":"Effect of a very-low-calorie diet on in\u00a0vitro fertilization outcomes","volume":"86","author":"Tsagareli","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib65","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1043-2760(02)00612-4","article-title":"The role of lifestyle modification in polycystic ovary syndrome","volume":"13","author":"Norman","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib66","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa0804748","article-title":"Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates","volume":"360","author":"Sacks","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib67","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.fertnstert.2003.08.023","article-title":"A\u00a0randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome","volume":"81","author":"Stamets","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib68","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.psyneuen.2008.06.003","article-title":"Women with polycystic ovary syndrome are often depressed or anxious\u2014a case control study","volume":"33","author":"M\u00e5nsson","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib69","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1210\/jc.2006-2794","article-title":"Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome","volume":"92","author":"Vigorito","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib70","doi-asserted-by":"crossref","first-page":"E48","DOI":"10.1210\/jc.2010-0828","article-title":"Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome","volume":"96","author":"Hutchison","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib71","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/humrep\/dem391","article-title":"Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study","volume":"23","author":"Palomba","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib72","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmv025","article-title":"Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis","volume":"21","author":"Naderpoor","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib73","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1210\/jc.2005-1490","article-title":"The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery","volume":"90","author":"Escobar-Morreale","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.01.006_bib74","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1001\/jama.2008.641","article-title":"Pregnancy and fertility following bariatric surgery: a systematic review","volume":"300","author":"Maggard","year":"2008","journal-title":"JAMA"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693416000079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693416000079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T11:00:04Z","timestamp":1537009204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693416000079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":74,"alternative-id":["S1521693416000079"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2016.01.006","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic syndrome, diet and exercise","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2016.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}